US Bancorp
ASMB icon

US Bancorp’s Assembly Biosciences ASMB Stock Holding History

US Bancorp’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.64K Hold
59
– – ﹤0.01% 3847
2025
Q4 		$2.01K Buy
+59
New +$1.9K ﹤0.01% 3754
2021
Q1 		– Sell
-13
Closed -$1K – 3872
2020
Q4 		$1K Hold
13
– – ﹤0.01% 3641
2020
Q3 		$3K Hold
13
– – ﹤0.01% 3395
2020
Q2 		$4K Buy
+13
New +$3.03K ﹤0.01% 3357
2018
Q4 		– Sell
-17
Closed -$7K – 3582
2018
Q3 		$7K Buy
+17
New +$7.96K ﹤0.01% 3227

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

US Bancorp's ASMB Position: Q1 2026 in Review

US Bancorp held its Assembly Biosciences (ASMB) position steady in Q1 2026 at 59 shares worth $1.64K. The position accounts for ﹤0.01% of the portfolio, ranked #3847.

US Bancorp first reported a position in ASMB in Q3 2018 and has held it in 6 quarters since. The position peaked at $7K in Q3 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • US Bancorp held 59 shares of Assembly Biosciences worth $1.64K as of Q1 2026.
  • US Bancorp left its Assembly Biosciences share count unchanged in Q1 2026.
  • Assembly Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #3847 holding.
  • US Bancorp first reported a position in Assembly Biosciences in Q3 2018 and has held it in 6 quarters since.
  • US Bancorp's Assembly Biosciences position peaked at $7K in Q3 2018.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.